Clinical Trials Program at Karmanos Cancer Institute
Karmanos Cancer Institute’s Clinical Trials Program is at the forefront of cancer research, offering patients access to the latest therapies and treatments. These trials are vital for advancing precision medicine, addressing disparities and improving outcomes for diverse populations. By participating in or supporting clinical trials at Karmanos, individuals can help pave the way for groundbreaking discoveries that impact cancer care worldwide. The program’s commitment to personalized medicine ensures patients receive innovative treatments tailored to their unique needs.
The Phase I Clinical Trials Multidisciplinary Team is central to the program and is pivotal in designing and conducting early-phase trials. This expert team includes medical oncologists, gynecologic oncologists and researchers who work collaboratively to ensure each patient has a treatment plan designed to achieve the best possible outcome. Our patients can expect to have a passionate, caring, expert team that gives them the best chance of success. Their efforts provide patients access to cutting-edge therapies that are often only available at Karmanos.
Recent efforts, like breast cancer biomarker studies, highlight Karmanos’ focus on inclusivity and innovation. Donations to the Clinical Trials Program help fund vital research, enhance patient care and expand the reach of innovative therapies. Now is a great time to give back; with the holiday season here, it’s a meaningful time to contribute to lifesaving research. By contributing to Karmanos, you become a partner in the fight against cancer, giving hope to patients and families.
Visit Karmanos Clinical Trials to learn more.
